close to approving another new drug for obesity
The FDA is getting close to approving another new drug for obesity...Meridia (sibutramine) from Knoll.
Meridia inhibits the reuptake of serotonin and norepinephrine. It's in the same class as the antidepressant Effexor (venlafaxine).
In fact, Meridia was originally developed for use as an antidepressant. The manufacturer switched gears when they noticed that it causes weight loss. The weight loss market is a lot less crowded than the antidepressant market.